These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22393910)

  • 81. Adipogenesis inhibitory effects of
    Kwon MS; Karadeniz F; Kim JA; Seo Y; Kong CS
    Food Sci Biotechnol; 2016; 25(Suppl 1):125-131. PubMed ID: 30263497
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.
    Lan GB; Xie XB; Peng LK; Liu L; Song L; Dai HL
    Biomed Res Int; 2015; 2015():413169. PubMed ID: 26649301
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Bisphosphonate therapy and osteonecrosis of the jaw complicated with a temporal abscess in an elderly woman with rheumatoid arthritis: a case report.
    Manzon L; Ettorre E; Viscogliosi G; Ippoliti S; Filiaci F; Ungari C; Fratto G; Agrillo A
    Clin Interv Aging; 2014; 9():1409-13. PubMed ID: 25187700
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Corticosteroid-induced osteoporosis: an update for dermatologists.
    Clarke BL
    Am J Clin Dermatol; 2012 Jun; 13(3):167-90. PubMed ID: 22393910
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Glucocorticoid-induced osteoporosis: an update.
    Mazziotti G; Angeli A; Bilezikian JP; Canalis E; Giustina A
    Trends Endocrinol Metab; 2006; 17(4):144-9. PubMed ID: 16678739
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
    Li M; Saito T; Amizuka N
    Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bone and glucocorticoids.
    Briot K
    Ann Endocrinol (Paris); 2018 Jun; 79(3):115-118. PubMed ID: 29685453
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT; Yosipovitch G
    Arch Dermatol; 2006 Jan; 142(1):82-90. PubMed ID: 16415391
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Glucocorticoid-induced osteoporosis: an update on effects and management.
    Buehring B; Viswanathan R; Binkley N; Busse W
    J Allergy Clin Immunol; 2013 Nov; 132(5):1019-30. PubMed ID: 24176682
    [TBL] [Abstract][Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.